2nd Annual ADC Summit 2013 London, 20-21 May

news headlines

email to a friend

printer friendly

2nd Annual ADC Summit 2013 London, 20-21 May

Main Category: Conferences

Article Date: 06 Feb 2013

SMi's ADC Summit 2013 has returned and will be held on the 20th to 21st May. This year's event will present a unique insight into latest technological and scientific developments and will be the perfect platform for debate and problem-solving discussion as well as an in-depth view into novel innovations, developments and utilities of antibody-drug conjugates that will see world-renowned expert speakers from Immunogen, UCB, Bayer, MedImmune, Spirogen and Genentec.

SMi is pleased to confirm John Hartley, Head of Biology of Spirogen as one of the speakers of the upcoming event.

He will address the design and development of Antibody-Pyrrolobenzodiazepine Conjugates (PBD), advantages and disadvantages of PBD as ADC warheads and there will be a case study discussing the issues of moving forward. Delegates will be given a comprehensive overview of the latest developments in payload delivery and linker strategies, Formulation developments in ADC, recent clinical developments and novel linker strategies.

For the full conference programme and further information please visit http://www.smi-online.co.uk/goto/adcsummit22.asp or contact Fateja Begum on +44 0 207 827 6184 or email fbegum@smi-online.co.uk

Original article posted on Medical News Today.
Articles not to be reproduced without permission of Medical News Today

Medical News Today publishes the latest health news and health videos for consumers and health professionals. It has a searchable archive of over 100,000 health news articles.

< back to medical news

For any corrections of factual information, or to contact the editors please use our feedback form.

Send your press releases to